Your session is about to expire
← Back to Search
ESG Procedure for Obesity
Study Summary
This trial aims to study the effectiveness of endoscopic sleeve gastroplasty (ESG) in treating obesity. ESG is an approved procedure by the FDA for patients with a BMI of 30-
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current number of participants involved in this research trial?
"Yes, as per clinicaltrials.gov, this clinical trial is actively seeking participants. The trial was initially listed on February 28, 2024, and last updated on March 24, 2024. The study aims to enroll 150 patients distributed across 2 sites."
Are there any available positions for patients to participate in this clinical trial?
"Indeed, information from clinicaltrials.gov shows that this research study is actively seeking eligible participants. The trial was first listed on February 28, 2024, and the most recent update was on March 24, 2024. Enrollment aims to recruit 150 individuals from two designated sites."
Share this study with friends
Copy Link
Messenger